Concourse Financial Group Securities’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8289 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8470 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8472 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8485 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8488 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8420 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8213 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8004 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7711 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7719 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7543 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7441 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7303 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7185 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6952 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6703 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6472 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6272 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6061 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5905 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5831 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5744 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5587 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5624 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5527 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5437 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5266 |
|